213 related articles for article (PubMed ID: 20547041)
1. Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria.
Carroll J; Draper LA; O'Connor PM; Coffey A; Hill C; Ross RP; Cotter PD; O'Mahony J
Int J Antimicrob Agents; 2010 Aug; 36(2):132-6. PubMed ID: 20547041
[TBL] [Abstract][Full Text] [Related]
2. Gene encoded antimicrobial peptides, a template for the design of novel anti-mycobacterial drugs.
Carroll J; Field D; O'Connor PM; Cotter PD; Coffey A; Hill C; Ross RP; O'Mahony J
Bioeng Bugs; 2010; 1(6):408-12. PubMed ID: 21468208
[TBL] [Abstract][Full Text] [Related]
3. Intracellular pH of Mycobacterium avium subsp. paratuberculosis following exposure to antimicrobial compounds monitored at the single cell level.
Gaggìa F; Nielsen DS; Biavati B; Siegumfeldt H
Int J Food Microbiol; 2010 Jul; 141 Suppl 1():S188-92. PubMed ID: 20573414
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species.
Piper C; Draper LA; Cotter PD; Ross RP; Hill C
J Antimicrob Chemother; 2009 Sep; 64(3):546-51. PubMed ID: 19561147
[TBL] [Abstract][Full Text] [Related]
5. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.
Molina-Torres CA; Ocampo-Candiani J; Rendón A; Pucci MJ; Vera-Cabrera L
Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antimycobacterial activity of 2-substituted halogenobenzimidazoles.
Kazimierczuk Z; Andrzejewska M; Kaustova J; Klimesova V
Eur J Med Chem; 2005 Feb; 40(2):203-8. PubMed ID: 15694655
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization and antimycobacterial activity of Ag(I)-aspartame, Ag(I)-saccharin and Ag(I)-cyclamate complexes.
Cavicchioli M; Leite CQ; Sato DN; Massabni AC
Arch Pharm (Weinheim); 2007 Oct; 340(10):538-42. PubMed ID: 17912678
[TBL] [Abstract][Full Text] [Related]
9. The inhibitory effect of nisin on Mycobacterium avium ssp. paratuberculosis and its effect on mycobacterial cell wall.
Ali ZI; Saudi AM; Albrecht R; Talaat AM
J Dairy Sci; 2019 Jun; 102(6):4935-4944. PubMed ID: 30981481
[TBL] [Abstract][Full Text] [Related]
10. Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations.
Morgan SM; O'connor PM; Cotter PD; Ross RP; Hill C
Antimicrob Agents Chemother; 2005 Jul; 49(7):2606-11. PubMed ID: 15980326
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of linezolid, clarithromycin and moxifloxacin against clinical isolates of Mycobacterium kansasii.
Guna R; Muñoz C; Domínguez V; García-García A; Gálvez J; de Julián-Ortiz JV; Borrás R
J Antimicrob Chemother; 2005 Jun; 55(6):950-3. PubMed ID: 15824090
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antimycobacterial evaluation of N-substituted 3-aminopyrazine-2,5-dicarbonitriles.
Zitko J; Jampílek J; Dobrovolný L; Svobodová M; Kuneš J; Doležal M
Bioorg Med Chem Lett; 2012 Feb; 22(4):1598-601. PubMed ID: 22281187
[TBL] [Abstract][Full Text] [Related]
13. New series of isoniazid hydrazones linked with electron-withdrawing substituents.
Vavříková E; Polanc S; Kočevar M; Košmrlj J; Horváti K; Bosze S; Stolaříková J; Imramovský A; Vinšová J
Eur J Med Chem; 2011 Dec; 46(12):5902-9. PubMed ID: 22018878
[TBL] [Abstract][Full Text] [Related]
14. Antimycobacterial activity of natural and semi-synthetic lignans.
Silva ML; Martins CH; Lucarini R; Sato DN; Pavanb FR; Freitas NH; Andrade LN; Pereira AC; Bianco TN; Vinholis AH; Cunha WR; Bastos JK; Silva R; Da Silva Filho AA
Z Naturforsch C J Biosci; 2009; 64(11-12):779-84. PubMed ID: 20158145
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro antimycobacterial activity of 2-methoxybenzanilides and their thioxo analogues.
Kozic J; Novotná E; Volková M; Stolaříková J; Trejtnar F; Vinšová J
Eur J Med Chem; 2012 Oct; 56():387-95. PubMed ID: 22907036
[TBL] [Abstract][Full Text] [Related]
16. [In vitro antimycobacterial activity of a new quinolone, T-3761].
Tomioka H; Sato K; Saito H
Kekkaku; 1995 Feb; 70(2):97-101. PubMed ID: 7699982
[TBL] [Abstract][Full Text] [Related]
17. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
[TBL] [Abstract][Full Text] [Related]
18. New rifabutin analogs: synthesis and biological activity against Mycobacterium tuberculosis.
Barluenga J; Aznar F; García AB; Cabal MP; Palacios JJ; Menéndez MA
Bioorg Med Chem Lett; 2006 Nov; 16(22):5717-22. PubMed ID: 16987658
[TBL] [Abstract][Full Text] [Related]
19. In vitro antimicrobial activities of capuramycin analogues against non-tuberculous mycobacteria.
Dubuisson T; Bogatcheva E; Krishnan MY; Collins MT; Einck L; Nacy CA; Reddy VM
J Antimicrob Chemother; 2010 Dec; 65(12):2590-7. PubMed ID: 20952419
[TBL] [Abstract][Full Text] [Related]
20. Antimycobacterial activity of synthetic pamamycins.
Lefèvre P; Peirs P; Braibant M; Fauville-Dufaux M; Vanhoof R; Huygen K; Wang XM; Pogell B; Wang Y; Fischer P; Metz P; Content J
J Antimicrob Chemother; 2004 Oct; 54(4):824-7. PubMed ID: 15317744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
